Skip to main content

Table 1 Patient demographics and clinical characteristics

From: p21 and CD166 as predictive markers of poor response and outcome after fluorouracil-based chemoradiotherapy for the patients with rectal cancer

Characteristics

Characteristic

No (%)

Sex

Male

74 (66.1%)

Female

38 (33.9%)

Age

Range, median

33 ~ 82, 62

ECOG Performance status

0

3 (2.7)

1

103 (92.0)

2

5 (4.5)

3

1 (0.9)

Histology

Adenocarcinoma

111 (99.1%)

AdenoSquamous carcinoma

1 (0.9%)

Differentiation

Well differentiated

20 (17.9)

Moderatly differentiated

86 (76.8)

Poorly differentiated

6 (5.4)

cT

1

0 (0%)

2

1 (1%)

3

97 (86.5%)

4

14 (12.5%)

cN

0

46 (41.1%)

1

48 (42.9%)

2

18 (16.1%)

Turmor regression grade (Dworak)

1

18 (16.1%)

2

48 (42.9%)

3

26 (23.2%)

4

20 (17.9%)

ypT

0 (total regression)

20 (17.9%)

1

3 (2.7%)

2

31 (27.7%)

3

55 (49.1%)

4

1 (0.9%)

Unknown

2 (1.7%)

ypN

0

79 (70.5%)

1

23 (20.5%)

2

10 (8.9%)

Unkonwn

2 (1.7%)

Circumferential resection margin

Median, range (cm)

1.0 (0.01,2.5)